REVOLAX™ DEEP with Lidocaine

REVOLAX™ DEEP with Lidocaine

Brand: Skin Lab Medical
30.00 GBP In stock Buy at Merchant

REVOLAX™ Deep with Lidocaine is a premium cross linked hyaluronic acid dermal filler designed to provide enhanced volume, contouring and wrinkle correction. With its medium to high viscosity gel, REVOLAX Deep delivers smooth, natural looking results while offering excellent longevity and tissue integration. Formulated with high purity hyaluronic acid and 0.3% lidocaine for increased patient comfort, REVOLAX Deep is ideal for treating deeper facial folds, restoring lost volume and enhancing facial contours with precision. Key Benefits * Smooths moderate to deep facial lines and wrinkles * Restores volume and enhances facial contours * Provides natural looking, long lasting results * High purity cross linked hyaluronic acid formula * Contains 0.3% lidocaine for improved treatment comfort * Excellent mouldability and tissue integration * Stable gel structure for reliable performance * CE certified and manufactured in South Korea Ideal Treatment Areas * Nasolabial folds * Marionette lines * Cheek augmentation * Chin enhancement * Jawline contouring * Lip enhancement * Facial volume restoration Product Specifications Product: REVOLAX™ Deep with Lidocaine Volume: 1.1ml Hyaluronic Acid Concentration: 24mg/ml Lidocaine: 0.3% Technology: Cross Linked Hyaluronic Acid Placement Depth: Mid to deep dermis Origin: South Korea Why Choose REVOLAX Deep? REVOLAX Deep is one of the most versatile fillers in the REVOLAX range, offering the perfect balance between lift, flexibility and longevity. Its advanced formulation allows practitioners to achieve defined yet natural looking results across multiple treatment areas, making it a popular choice for facial rejuvenation and contouring procedures. Professional use only. Intended for use by trained medical and aesthetic practitioners.

Variants (1)
  • Default Title — 30.00 GBP — In stock

AI Readiness

Good foundation, but some important product data is still missing.

72%